Company: IXHL
Filing Date: 2025-10-27
Form Type: DEF 14A
Source: 0001213900-25-102654
Chunk: 36

Company: Incannex Healthcare Inc.
Filing Date: 2025-10-27
Form: DEF 14A
Chunk 36
---
25 Proposal No. 1 ELECTION OF CLASS II DIRECTORS On October 1, 2025, as recommended by the independent members of the board of directors, Dr. George Anastassov and Robert Clark were nominated for election at the Annual Meeting. The board of directors currently consists of five members, classified into three classes as follows: Dr. George Anastassov and Robert Clark constitute a class with a term ending at the Annual Meeting; Joel Latham and Troy Valentine constitute a class with a term ending at the 2026 annual meeting of stockholders; and Peter Widdows solely constitutes a class with a term ending at the 2027 annual meeting of stockholders. At each annual meeting of stockholders, directors are elected for a full term of three years to succeed those directors whose terms are expiring. The board of directors, as recommended by the independent members of the board of directors, has voted to nominate Dr. George Anastassov and Robert Clark for election at the Annual Meeting for a term of three years to serve until the 2028 annual meeting of stockholders, and until their respective successors have been elected and qualified, subject to their earlier death, resignation, disqualification or removal. The Class III directors (Joel Latham and Troy Valentine) and the Class I director (Peter Widdows) will serve until the annual meetings of stockholders to be held in 2026 and 2027, respectively, and until their respective successors have been elected and qualified, subject to their earlier death, resignation, disqualification or removal. Unless authority to vote for Dr. George Anastassov and Robert Clark is withheld, the shares represented by the enclosed proxy will be voted FORthe election of Dr. George Anastassov and Robert Clark as Class II directors. In the event that Dr. Anastassov or Mr. Clark become unable or unwilling to serve, the shares represented by the enclosed proxy will be voted for the election of such other person as the board of directors may recommend in his place. We have no reason to believe that Dr. Anastassov or Mr. Clark will be unable or unwilling to serve as a director. A plurality of the shares voted FOReach nominee at the Annual Meeting is required to elect each nominee as director. THE board of directors Recommends The Election Of DR. GEORGE ANASTASSOV AND ROBERT CLARK As CLASS II DirectorS, And Proxies Solicited By THE board of directors Will Be Voted In Favor Thereof Unless A Stockholder Has Indicated